Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 2 | IL-17 | 40.0 | 61 | ||||
RA2159 | 2 | IL-17 | 37.5 | 68 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | IL-17 | 36.5 | 66 | ||||
N2645 | 2 | IL-17 | 41.0 | 59 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | IL-17 | 39.0 | 63 | ||||
RA2708 | 2 | IL-17 | 40.5 | 70 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 88.0 | 71 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 105.0 | 59 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 92.5 | 72 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 99.0 | 81 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 77.5 | 78 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 100.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 117.0 | 48 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | IL-17 | 127.5 | 68 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 116.5 | 54 | |
N2645 | TNF-a | 100 | ng/mL | 2 | IL-17 | 111.0 | 70 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IL-17 | 104.0 | 59 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | IL-17 | 122.0 | 41 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 35.0 | 65 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 45.0 | 76 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 34.5 | 58 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 51.0 | 59 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 39.0 | 85 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 45.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-17 | 96.0 | 59 |